Empagliflozin controls cirrhotic refractory ascites along with improvement of natriuresis and circulatory, cardiac, and renal function: A pilot study

Eur J Intern Med. 2024 Dec:130:162-164. doi: 10.1016/j.ejim.2024.08.012. Epub 2024 Aug 19.

Authors

Georgios Kalambokis¹, Ilias Tsiakas², Sebastien Filippas-Ntekouan², Maria Christaki², Haralampos Milionis²

Affiliations

¹ First Division of Internal Medicine, Medical School, University of Ioannina, Ioannina 45110, Greece. Electronic address: [email protected].
² First Division of Internal Medicine, Medical School, University of Ioannina, Ioannina 45110, Greece.

PMID: 39164154
DOI: 10.1016/j.ejim.2024.08.012

No abstract available

Keywords: Circulatory function; Cirrhosis; Empagliflozin; Natriuresis; Refractory ascites; Renal function.

Publication types

Letter